Patent · US Active

Lanthanum composition

US8974824B2 · kind B2 · utility

3Cited by

3References

14Claims

0Family size

Assignee

Mylan Laboratories Limited · IN

Inventors

Nagaraj Amminabavi · Secunderabad, IN
Indu Bhushan · Bengaluru, IN
Satish Kumar JAIN · Bilaspur, IN
Subhash Gore · Secunderabad, IN
Gnanadeva Chalapathy Gudipati · Secunderabad, IN
Balakrishnan Chinnu · Secunderabad, IN
Subramanian Iyer · Secunderabad, IN
Manoj P Kumar · Secunderabad, IN
Rajesh S Gupta · Secunderabad, IN

Key dates

Filing date	Mar 24, 2009
Grant date	Mar 10, 2015
Priority date	—
Expiry date	Jun 13, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2077
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and pharmaceutically acceptable carriers or diluents, wherein said carrier or diluent excludes monosaccharide/s or disaccharide/s, such that the composition has comparable in-vitro dissolution profile similar to that of FOSRENOL®.Also disclosed is a wet granulation process for making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.